Chartoreg 40 mg 28 tablets

Trade name:

Chartoreg 40 mg 28 tablets.

Composition:

Each tablet contains: 40 mg telmisartan as active ingredient.

Inactive ingredient: Sodium hydroxide – Povidone k 30 – Meglumine – Mannitol – Magnesium stearate – Talc – colloidal silicon dioxide (aerosil 200).

Indications:

-Hypertension

Chartoreg is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. 

Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. 

Dosage:

-Hypertension

Dosage must be individualized. The usual starting dose of Chartoreg tablets is 40 mg once a day. Blood pressure response is dose-related over the range of 20 to 80 mg.

Most of the antihypertensive effect is apparent within 2 weeks and maximal reduction is generally attained after 4 weeks. 

-No initial dosage adjustment is necessary for elderly patients or patients with renal impairment, including those on hemodialysis. Patients on dialysis may develop orthostatic hypotension; their blood pressure should be closely monitored.

-Chartoreg tablets may be administered with other antihypertensive agents.

-Chartoreg tablets may be administered with or without food.

-Cardiovascular Risk Reduction

The recommended dose of chartoreg tablets is 80 mg once a day and can be administered with or without food. It is not known whether doses lower than 80 mg of telmisarian are effective in reducing the risk of cardiovascular morbidity and mortality.

Contraindications:

-The concomitant use of telmisartan with aliskiren-containing products is contraindicated in patients with diabetes mellitus or renal impairment

-Chartoreg is contraindicated in patients with known hypersensitivity to telmisartan or any other component of this product.

Side Effects:

headache, dizziness, asthenia, coughing, nausea, fatigue, weakness, edema, faca olasma, lower limb edema, angioneurotic eclema, urticaria, hypersensitivity, sweating increased, erythma, chest pain, atrial fibrillation, congestive heart failure, myocardial infarclion.

Pregnancy:

Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.

Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. 

When pregnancy is detected, discontinue Chartoreg as soon as possible. 

Storage:

Store in temperature exceeding 30 C in a dry place

Keep out of reach of children

Package:

A carton box contains 28 tablets.